Score Overview
Explore the 2021 public Archive ranking →
Where LivaNova PLC has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 30 years of fundamentals. LIVN does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 77.21 | — |
1 Year2025-09-26 | $ 53.44 | 44.48% |
5 Years2021-09-28 | $ 81.08 | -4.77% |
10 Years2016-09-28 | $ 60.97 | 26.64% |
20 Years2006-09-28 | $ 17.64 | 337.70% |
30 Years1996-09-26 | $ 6.25 | 12x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-26 |
|---|---|---|---|---|---|---|
| Price | $ 77.21 | $ 53.44 | $ 81.08 | $ 60.97 | $ 17.64 | $ 6.25 |
| Return | — | 44.48% | -4.77% | 26.64% | 337.70% | 12x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 1.47B | $ 188M | $ 516M |
| 2025 | $ 1.38B | -$ 242M | $ 635M |
| 2024 | $ 1.25B | $ 63M | $ 428M |
| 2023 | $ 1.15B | $ 17M | $ 266M |
| 2022 | $ 1.02B | -$ 86M | $ 214M |
| 2021 | $ 1.03B | -$ 135M | $ 207M |
| 2020 | $ 934M | -$ 348M | $ 252M |
| 2019 | $ 1.08B | -$ 157M | $ 61M |
| 2018 | $ 1.10B | -$ 189M | $ 47M |
| 2017 | $ 1.01B | -$ 25M | $ 93M |
| 2016 | $ 1.21B | -$ 62M | $ 39M |
| 2015 | $ 291M | $ 57M | $ 119M |
| 2014 | $ 282M | $ 54M | $ 128M |
| 2013 | $ 282M | $ 54M | $ 128M |
| 2012 | $ 254M | $ 46M | $ 135M |
| 2011 | $ 218M | $ 36M | $ 96M |
| 2010 | $ 190M | $ 46M | $ 89M |
| 2009 | $ 167M | $ 78M | $ 85M |
| 2008 | $ 143M | $ 26M | $ 54M |
| 2007 | $ 121M | -$ 10M | $ 62M |
| 2006 | $ 130M | -$ 51M | $ 89M |
| 2005 | $ 123M | -$ 59M | $ 92M |
| 2004 | $ 103M | -$ 12M | $ 61M |
| 2003 | $ 110M | $ 6M | $ 58M |
| 2002 | $ 104M | $ 5M | $ 57M |
| 2001 | $ 70M | -$ 26M | $ 39M |
| 2000 | $ 43M | $ 43M | |
| 1999 | $ 47M | -$ 3M | $ 16M |
| 1998 | $ 29M | -$ 12M | $ 20M |
| 1997 | $ 14M | -$ 14M | $ 200K |
| 1996 | $ 1M | -$ 11M | $ 18M |
| 1995 | $ 1M | -$ 10M | $ 2M |
| 1994 | $ 1M | -$ 7M | $ 6M |
| IPO1993 | $ 400K | -$ 5M | $ 4M |
LivaNova PLC fundamental performance
Between 2020 and 2025, revenue grew from $ 934M to $ 1.38B and net income went from -$ 348M to -$ 242M. Revenue increased in 4 of those 5 years; net income in 4.
Across LivaNova PLC's full reported history, from 1993 to 2025, revenue grew from $ 400K to $ 1.38B and net income went from -$ 5M to -$ 242M. Revenue increased in 73% of the years measured; net income in 58%.
LivaNova PLC currently holds a 20-year HDB Score of 5.4 out of 10. How the HDB Score is calculated.
Membership
Explore LIVN with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Ligand Pharmaceuticals IncorporatedLGND· revenue grew in 75% of years
Bristol-Myers Squibb CompanyBMY· revenue grew in 65% of years
Corcept Therapeutics IncorporatedCORT· revenue grew in 89% of years
Bruker CorporationBRKR· revenue grew in 80% of years
National Research CorpNRC· revenue grew in 85% of years
